A Phase II Study of Single Agent Clofarabine in Previously Untreated Older Adult Patients With Acute Myelogenous Leukemia (AML) for Whom Standard Induction Chemotherapy is Unlikely to be of Benefit.

Trial Profile

A Phase II Study of Single Agent Clofarabine in Previously Untreated Older Adult Patients With Acute Myelogenous Leukemia (AML) for Whom Standard Induction Chemotherapy is Unlikely to be of Benefit.

Completed
Phase of Trial: Phase II

Latest Information Update: 24 Aug 2013

At a glance

  • Drugs Clofarabine (Primary)
  • Indications Acute myeloid leukaemia
  • Focus Therapeutic Use
  • Acronyms CLASSIC-II
  • Most Recent Events

    • 29 Dec 2010 Actual end date changed from Mar 2010 to May 2010 as reported by ClinicalTrials.gov.
    • 29 Dec 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 24 Nov 2009 M.D. Anderson Cancer Center reports actual start date (23 Oct 2006) and planned number of patients (109).
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top